Trademark: 85248221
Word
AMPLE - ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE
Status
Dead
Status Code
606
Status Date
Monday, August 26, 2013
Serial Number
85248221
Mark Type
4000
Filing Date
Tuesday, February 22, 2011
Published for Opposition
Tuesday, May 31, 2011
Abandoned Date
Monday, August 26, 2013

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
42 Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
"ABATACEPT VERSUS ADALIMUMAB COMPARISON IN BIOLOGIC-NAIVE RA SUBJECTS WITH BACKGROUND METHOTREXATE"

Trademark Events
Aug 26, 2013
Abandonment Notice Mailed - No Use Statement Filed
Aug 26, 2013
Abandonment - No Use Statement Filed
Mar 12, 2013
Teas Change Of Correspondence Received
Jan 16, 2013
Notice Of Approval Of Extension Request Mailed
Jan 15, 2013
Extension 3 Granted
Jan 11, 2013
Extension 3 Filed
Jan 11, 2013
Teas Extension Received
Jul 4, 2012
Notice Of Approval Of Extension Request Mailed
Jul 3, 2012
Extension 2 Granted
Jun 28, 2012
Extension 2 Filed
Jun 28, 2012
Teas Extension Received
Jan 26, 2012
Notice Of Approval Of Extension Request Mailed
Jan 25, 2012
Extension 1 Granted
Dec 22, 2011
Extension 1 Filed
Jan 25, 2012
Case Assigned To Intent To Use Paralegal
Dec 22, 2011
Teas Extension Received
Jul 26, 2011
Noa Mailed - Sou Required From Applicant
May 31, 2011
Published For Opposition
May 11, 2011
Notice Of Publication
Apr 28, 2011
Law Office Publication Review Completed
Apr 28, 2011
Approved For Pub - Principal Register
Apr 19, 2011
Attorney Revoked And/Or Appointed
Apr 19, 2011
Teas Revoke/Appoint Attorney Received
Apr 20, 2011
Examiner's Amendment Mailed
Apr 19, 2011
Examiner's Amendment Entered
Apr 19, 2011
Assigned To Lie
Apr 19, 2011
Examiners Amendment -Written
Apr 18, 2011
Assigned To Examiner
Feb 25, 2011
New Application Office Supplied Data Entered In Tram
Feb 25, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24